For years, cardiologists have generally pictured heart aging as a gradual, roughly uniform process spread across the organ. A new study from researchers at the Jackson Laboratory suggests that picture is wrong, at least in mice: the molecular signs of an aging heart turn out to cluster tightly in specific spots, particularly the aortic valve and the aortic root, rather than appearing evenly across the muscle.
The study, led by immunologist Nadia Rosenthal and published in the journal Aging Cell, used single-cell and spatial genomics to profile thousands of individual cells from young and aged laboratory mice that lived in identical conditions and ate identical diets. That control, the researchers say, let them isolate the effects of aging itself from environmental differences that often confound human studies.
Hotspots, Not a Uniform Decline
The team found that two cell types drove most of the age-related change: macrophages, which showed heightened activity in genes tied to inflammation and tissue remodeling, and fibroblasts, which shifted toward patterns associated with fibrosis, or scarring. Two genes in particular, Ccl8 and the senescence marker Cdkn1a (also known as p21), rose with age and were concentrated in the same valve and root regions described in the Jackson Laboratory's announcement of the findings.
The researchers also found an unexpected sex difference: in male mice, aging fibroblasts leaned toward fibrosis-related activity, while in females they leaned toward pathways tied to development and protein production. Comparing their mouse data against previously published human heart datasets, the team found some of the same age-related stress-response programs showing up in both species, though that comparison relied on existing data rather than a new human cohort.
We really have to think of aging as something that is not linear.
Nadia Rosenthal, The Jackson Laboratory
Rosenthal cautioned against reading too much into standard aging-cell markers on their own. Some of the same senescence-associated markers used to flag "old" cells turned up in young mouse hearts too, in places the team didn't expect — a reminder, she said, that "there's nothing senescent about a six-month-old mouse heart" just because a marker lights up. Study author Aleksandra Aljakna Khan credited the controlled setup for the clarity of the result: "Because all of the mice in our study lived in the same environment and ate the same diet, we were able to isolate the effects of aging," she said.
The work was funded by the National Institutes of Health through the Jackson Laboratory's Senescence Tissue Mapping Center and its Cancer Center, with no industry funding involved. It is also, by the researchers' own account, a map rather than a treatment: the findings point to where in the aging heart to look for trouble, particularly around the valves, but they don't yet show whether targeting those hotspots would change the course of cardiovascular disease, and the central result has so far been demonstrated only in mice.